US Stock MarketDetailed Quotes

INZY Inozyme Pharma

Watchlist
  • 4.630
  • +0.120+2.66%
Close May 14 16:00 ET
  • 4.740
  • +0.110+2.38%
Post 16:55 ET
286.39MMarket Cap-3429P/E (TTM)

Inozyme Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Inozyme Pharma Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.38

+5.00%
Analyst Rating

Strong Buy

Apr 9, 2024

Inozyme Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Inozyme Pharma Earnings Reports

  • Inozyme Pharma | 10-Q: Quarterly report

    May 7 20:34

  • Inozyme Pharma | 10-K: Annual report

    Mar 12 20:37

  • Inozyme Pharma: Q3 2023 Earnings Report

    Nov 7, 2023 21:34

  • Inozyme Pharma | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 21:03

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 9, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg